Kong X - Search Results

1

Research and development of anti-Alzheimer's drugs: an analysis based on technology flows measured by patent citations.

Xu J, Kong X, Qiu L, Geng X, Hu Y, Wang Y. Xu J, et al. Among authors: kong x. Expert Opin Ther Pat. 2014 Jul;24(7):791-800. doi: 10.1517/13543776.2014.915943. Epub 2014 May 5. Expert Opin Ther Pat. 2014. PMID: 24798577 Review.

2

Research and development of antibiotics: insights from patents and citation network.

Zhang M, Kong X, Zheng J, Wan JB, Wang Y, Hu Y, Shao R. Zhang M, et al. Among authors: kong x. Expert Opin Ther Pat. 2016 May;26(5):617-27. doi: 10.1517/13543776.2016.1167877. Epub 2016 Apr 6. Expert Opin Ther Pat. 2016. PMID: 26986226 Review.

3

Global patent landscape of programmed cell death 1: implications of the rapid expansion.

Kong X, Zhang Q, Lai Y, Hu H, Chen X, Hu Y. Kong X, et al. Expert Opin Ther Pat. 2018 Jan;28(1):69-80. doi: 10.1080/13543776.2017.1378349. Epub 2017 Sep 19. Expert Opin Ther Pat. 2018. PMID: 28891360 Review.

4

Dendritic-cell-based technology landscape: Insights from patents and citation networks.

Kong X, Hu Y, Cai Z, Yang F, Zhang Q. Kong X, et al. Hum Vaccin Immunother. 2015;11(3):682-8. doi: 10.1080/21645515.2015.1008857. Hum Vaccin Immunother. 2015. PMID: 25714961 Free PMC article. Review.

5

Research and development of therapeutic mAbs: An analysis based on pipeline projects.

Geng X, Kong X, Hu H, Chen J, Yang F, Liang H, Chen X, Hu Y. Geng X, et al. Among authors: kong x. Hum Vaccin Immunother. 2015;11(12):2769-76. doi: 10.1080/21645515.2015.1074362. Hum Vaccin Immunother. 2015. PMID: 26211701 Free PMC article.

6

Trends involving monoclonal antibody (mAb) research and commercialization: A scientometric analysis of IMS Lifecycle R&D Focus Database (1980-2016).

Lai Y, Suo S, Wang R, Kong X, Hu Y, Tang D, Shi H, Chen S, Hu H. Lai Y, et al. Among authors: kong x. Hum Vaccin Immunother. 2018 Apr 3;14(4):847-855. doi: 10.1080/21645515.2017.1420445. Epub 2018 Jan 23. Hum Vaccin Immunother. 2018. PMID: 29293380 Free PMC article.

7

The Changing Global Landscape in the Development of Artemisinin-Based Treatments: A Clinical Trial Perspective.

Kong XJ, Liu KM, Zuo HL, Huang HD, Hu YJ. Kong XJ, et al. Am J Chin Med. 2022;50(3):733-748. doi: 10.1142/S0192415X22500306. Epub 2022 Mar 10. Am J Chin Med. 2022. PMID: 35282805 Review.

8

Research and development of mAb drugs in China: a look from policy perspectives.

Jiang R, Sun Y, Ung C, Dong X, Kong X, Hu Y, Shao R. Jiang R, et al. Among authors: kong x. Hum Vaccin Immunother. 2019;15(11):2695-2705. doi: 10.1080/21645515.2019.1605809. Epub 2019 May 22. Hum Vaccin Immunother. 2019. PMID: 31116629 Free PMC article.

9

Delivery of therapeutic small interfering RNA: The current patent-based landscape.

Chen Y, Xiong SH, Li F, Kong XJ, Ouyang DF, Zheng Y, Yu H, Hu YJ. Chen Y, et al. Mol Ther Nucleic Acids. 2022 Jun 22;29:150-161. doi: 10.1016/j.omtn.2022.06.011. eCollection 2022 Sep 13. Mol Ther Nucleic Acids. 2022. PMID: 35847171 Free PMC article.

10

Global landscape of patents related to human coronaviruses.

Liu K, Gu Z, Islam MS, Scherngell T, Kong X, Zhao J, Chen X, Hu Y. Liu K, et al. Among authors: kong x. Int J Biol Sci. 2021 Apr 10;17(6):1588-1599. doi: 10.7150/ijbs.58807. eCollection 2021. Int J Biol Sci. 2021. PMID: 33907523 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,883 results

Search Page

Filters